Overcoming PARP inhibitor resistance with molecularly guided rational combinations in triple-negative breast cancer patient-derived xenograft models

被引：0
|
作者：
Pico, Christian X. Cruz [1 ]
Evans, Kurt W. [1 ]
Chen, Ken [1 ]
Zheng, Xiaofeng [1 ]
Akcakanat, Argun [1 ]
Zhao, Ming [1 ]
Tapia, Coya [1 ]
Scott, Stephen M. [1 ]
Yuca, Erkan [1 ]
Meric-Bernstam, Funda [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-676A
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
676A
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The PARP inhibitor niraparib demonstrates robust activity in a subset of patient-derived triple-negative breast cancer xenograft models
    Wang, Yan
    Cairo, Stefano
    Nicolle, Delphine
    Cristescu, Razvan
    Loboda, Andrey
    Nebozhyn, Michael
    Zhang, Theresa
    Judde, Jean-Gabriel
    Wilcoxen, Keith
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [2] Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models
    Guo, Zhanfang
    Luo, Jingqin
    Mashl, R. Jay
    Hoog, Jeremy
    Maiti, Piyush
    Fettig, Nikki
    Davies, Sherri R.
    Aft, Rebecca
    Held, Jason M.
    Govindan, Ramaswamy
    Ding, Li
    Li, Shunqiang
    von Morze, Cornelius
    Wulf, Gerburg M.
    Shoghi, Kooresh I.
    Ma, Cynthia X.
    [J]. CANCER RESEARCH COMMUNICATIONS, 2024, 4 (06): : 1430 - 1440
  • [3] The PARP inhibitor niraparib demonstrated activity in patient-derived triple-negative breast cancer xenograft models with high homologous recombination deficiency (HRD) score
    Wang, Yan
    Cairo, Stefano
    Deas, Olivier
    Hartman, Anne-Renee
    Jones, Joshua
    Gutin, Alexander
    Lanchbury, Jerry
    Sangale, Zaina
    Solimeno, Cara
    Judde, Jean-Gabriel
    Timms, Kirsten
    Wilcoxen, Keith
    [J]. CANCER RESEARCH, 2015, 75
  • [4] Targeting ATR to overcome Carboplatin resistance in triple-negative breast cancer patient-derived models
    Guay, Juliet
    Chabot, Catherine
    Darini, Cedric
    Buchanan, Marguerite
    Aguilar-Mahecha, Adriana
    Kong, Tim
    Yang, Connie
    Basik, Mark
    Huang, Sidong
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [5] Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models
    Guo, Zhanfang
    Primeau, Tina
    Luo, Jingqin
    Zhang, Cynthia
    Sun, Hua
    Hoog, Jeremy
    Gao, Feng
    Huang, Shixia
    Edwards, Dean P.
    Davies, Sherri R.
    Aft, Rebecca
    Ding, Li
    Ellis, Matthew J.
    Li, Shunqiang
    Ma, Cynthia X.
    [J]. CANCERS, 2020, 12 (12) : 1 - 14
  • [6] Evaluating the metastatic potential and the molecular heterogeneity of patient-derived orthotopic xenograft models of triple-negative breast cancer
    Ramani, Vishnu C.
    Gupta, Rakhi
    Quon, Gerald
    Triboulet, Melanie
    Renier, Corinne
    Greene, Cassandra
    Sanada, Chad
    Lu, Tracy
    Szpankowski, Lukasz
    Ramalingam, Naveen
    Salahudeen, Ameen A.
    de la O, Sean
    Rajapaksa, Ranjani
    Levy, Shoshana
    Leyrat, Anne A.
    West, Jay A.
    Sollier-Christen, Elodie
    Kuo, Calvin J.
    Sledge, George W.
    Jeffrey, Stefanie S.
    [J]. CANCER RESEARCH, 2017, 77
  • [7] Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models
    Park, Hyung Seok
    Lee, Jeong Dong
    Kim, Jee Ye
    Park, Seho
    Kim, Joo Heung
    Han, Hyun Ju
    Choi, Yeon A.
    Choi, Ae Ran
    Sohn, Joo Hyuk
    Kim, Seung Il
    [J]. PLOS ONE, 2019, 14 (12):
  • [8] Pharmacologic profiling of patient-derived xenograft models of primary treatment-naive triple-negative breast cancer
    Powell, Reid T.
    Redwood, Abena
    Liu, Xuan
    Guo, Lei
    Cai, Shirong
    Zhou, Xinhui
    Tu, Yizheng
    Zhang, Xiaomei
    Qi, Yuan
    Jiang, Yan
    Echeverria, Gloria
    Feng, Ningping
    Ma, XiaoYan
    Giuliani, Virginia
    Marszalek, Joseph R.
    Heffernan, Timothy P.
    Vellano, Christopher P.
    White, Jason B.
    Stephan, Clifford
    Davies, Peter J.
    Moulder, Stacy
    Symmans, W. Fraser
    Chang, Jeffrey T.
    Piwnica-Worms, Helen
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [9] Identifying metastatic drivers in patient-derived xenograft models of triple negative breast cancer
    Powell, Emily
    Shao, Jiansu
    Picon, Hector M.
    Ge, Zhongqi
    Echeverria, Gloria V.
    Peoples, Michael
    Bristow, Christopher
    Cai, Shirong
    Tu, Yizheng
    McCoy, Aaron M.
    Piwnica-Worms, David
    Draetta, Giulio
    Edwards, John R.
    Moulder, Stacy L.
    Symmans, William F.
    Heffernan, Timothy P.
    Liang, Han
    Piwnica-Worms, Helen
    [J]. CANCER RESEARCH, 2018, 78 (04)
  • [10] Development of humanized patient-derived xenograft models for triple negative breast cancer.
    Her, Yujeong
    Son, Hye Yeon
    Kim, Ju Hee
    Heo, Woo Hang
    Quan, Mingji
    Li, Songbin
    Moon, Hyeong Gon
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345